Skip to content
Disclosery

EXANE DERIVATIVES: MCHP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MCHP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 11,467 MCHP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 11,467 shares
    Change vs previous 13F -3,138 shares

    0.38% of the 13F portfolio, value $665,867.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 14,605 shares
    Change vs previous 13F -871 shares

    0.31% of the 13F portfolio, value $1,097,402.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 15,476 shares
    Change vs previous 13F +12,188 shares

    0.33% of the 13F portfolio, value $1,347,353.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,288 shares
    Change vs previous 13F -1,399 shares

    0.13% of the 13F portfolio, value $504,680.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,687 shares
    Change vs previous 13F +4,256 shares

    0.16% of the 13F portfolio, value $674,603.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 431 shares
    Change vs previous 13F +188 shares

    0.02% of the 13F portfolio, value $66,900.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 243 shares
    Change vs previous 13F -32 shares

    0.01% of the 13F portfolio, value $33,561.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 275 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $28,259.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).